New IP covers topical rose bengal sodium ophthalmic composition against MRSA and other resistant Gram-positive bacteria without requiring light ...
Under Veripure, Provectus is supplying qualified medical researchers with the same pharmaceutical grade rose bengal sodium ...
Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that its 2026 annual ...
CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Successful long-term healthcare leaders at Provectus partner with Hucu.ai, a revolutionary patient-centered messaging platform, to drive provider ...
KNOXVILLE, TN, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from ongoing clinical trials of investigational cancer immunotherapy PV-10 (rose bengal sodium) for ...
KNOXVILLE, TN, June 26, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s shareholders have approved the proposals of Provectus’s Board of Directors (Board) to seek ...
KNOXVILLE, TN, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical research on a formulation of the Company’s pharmaceutical-grade rose bengal against ...
Detailed price information for Provectus Biopharmaceuticals Inc (PVCT) from The Globe and Mail including charting and trades.
Mr. Pershing has served as Board chairman since 2018 and was a Board observer and chairman of the Company’s Strategic Advisory Board from 2017 to 2018. Mr. Rodrigues has served as Provectus’s chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results